Nicotine is a cardiovascular drug first and a mood drug second. That is why the cardiovascular changes after quitting vaping show up so quickly: you are removing an active pharmacological input, not waiting for slow tissue repair.

Days 1-7: heart rate falls

Nicotine is a stimulant. It activates the sympathetic nervous system, raising heart rate by roughly 5-15 bpm above your true resting baseline. Within days of your last puff, that stimulus is gone and resting HR drops.

Practical marker: take a resting pulse before bed on quit day, and again on day 7. Most quitters see a 5-10 bpm drop.

Weeks 1-2: blood pressure normalises

In previously normotensive vapers, blood pressure returns to baseline within 1-2 weeks. If your pre-quit BP was elevated, don't assume it will fully normalise on its own; the vape was a contributor, not the only cause.

Months 1-3: endothelial function

Endothelial function — the ability of small blood vessels to dilate on demand — is impaired by vape aerosol in short-term studies. It improves measurably over the first 1-3 months of abstinence. Flow-mediated dilation (the standard research measurement) shifts back toward age-normal values.

This is the marker with the clearest published direction: every study of former vapers finds endothelial reactivity improving over months, not years.

Months 3-12: risk-factor trajectory

Traditional cardiovascular risk factors — resting HR, BP, lipid particle distribution, HbA1c in smokers — improve across the first year of smoking cessation. Vaper data mirrors this on the markers that have been measured. The absolute changes are smaller because the vape-exposed cardiovascular baseline was closer to healthy than the smoking one, but they trend in the same direction.

Year 1 and beyond

Long-term cardiovascular event data in never-smoker vapers is thin because widespread vaping is only ~15 years old and cardiovascular events accumulate over decades. What we can say:

  • Every marker measured moves favourably after quitting.
  • The smoking-cessation cardiovascular risk-reduction curve is a reasonable, if imperfect, comparator.
  • Absolute residual risk in former vapers who never smoked is expected to be lower than in former smokers, but is not zero.

The long-term-health pillar covers this alongside lung, oral, skin, and sleep recovery.

What can slow cardiovascular recovery

  • Continued caffeine escalation to compensate for lost nicotine.
  • Alcohol — see the alcohol and relapse piece.
  • Sedentary weeks after quitting. Aerobic activity accelerates every measured marker.
  • Untreated hypertension or dyslipidaemia that pre-dated the vape.

When to see a doctor

  • Chest pain or pressure, especially with exertion.
  • Persistent palpitations beyond withdrawal week one.
  • Shortness of breath at rest.
  • BP readings that stay high past week three.

Making it stick

The cardiovascular win from quitting shows up faster than almost anything else, which is why it's a good motivational anchor for week one. A resting pulse before quit day and a re-test at day 7 is one of the most concrete data points you'll have in the first month. See the what-happens-when-you-quit timeline for how it fits with everything else.